Tamra Burns Loeb1, Nataria T Joseph2, Gail E Wyatt1, Muyu Zhang1, Dorothy Chin1, April Thames3, Yvorn Aswad4. 1. Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles. 2. Social Sciences Division, Pepperdine University. 3. Department of Psychiatry, University of California, Los Angeles. 4. Charles R. Drew University of Medicine and Science, David Geffen School of Medicine at University of California, Los Angeles.
Abstract
OBJECTIVE: Somatic symptoms are often reported among victims of trauma, and place a significant burden on primary care health providers. We examined the relationship between lifetime histories of trauma and adversity, including aspects not previously studied (i.e., perceived discrimination), and somatic symptoms, as well as the mediating role of posttraumatic stress symptoms (PTSS) and depressive symptoms. METHOD: A multiethnic community sample of 500 male and female participants (230 African American and 270 Latino) completed measures of demographic characteristics, the University of California, Los Angeles Lifetime Adversities Screener (LADS), depressive symptoms, PTSS, and somatic symptoms. RESULTS: An ordinary least-squares regression analysis controlling for age, gender, and race/ethnicity indicated that higher levels of lifetime adversity and trauma were significantly associated with more severe somatic symptoms (b = 6.95, p < .0001). Formal mediation tests indicated that there was a significant indirect effect of LADS on somatic symptoms via PTSS and depressive symptoms, indirect effect = 2.64 (95% confidence interval [CI] [1.2, 4.1]) and 2.19 (95% CI [1.3, 3.3]), respectively. Even after PTSS and depressive symptoms were taken into account, the LADS remained significantly associated with somatic symptoms (b = 2.13, p < .05), suggesting partial mediation. CONCLUSION: Exposure to traumatic and adverse events (the LADS) was associated with somatic symptom severity. Furthermore, although PTSS and depressive symptoms partially accounted for the association between the LADS and somatic symptoms, the LADS remained significant, suggesting that both exposure to trauma and adversity and the resultant development of PTSS and depressive symptoms influence the development of somatic symptoms. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
OBJECTIVE: Somatic symptoms are often reported among victims of trauma, and place a significant burden on primary care health providers. We examined the relationship between lifetime histories of trauma and adversity, including aspects not previously studied (i.e., perceived discrimination), and somatic symptoms, as well as the mediating role of posttraumatic stress symptoms (PTSS) and depressive symptoms. METHOD: A multiethnic community sample of 500 male and female participants (230 African American and 270 Latino) completed measures of demographic characteristics, the University of California, Los Angeles Lifetime Adversities Screener (LADS), depressive symptoms, PTSS, and somatic symptoms. RESULTS: An ordinary least-squares regression analysis controlling for age, gender, and race/ethnicity indicated that higher levels of lifetime adversity and trauma were significantly associated with more severe somatic symptoms (b = 6.95, p < .0001). Formal mediation tests indicated that there was a significant indirect effect of LADS on somatic symptoms via PTSS and depressive symptoms, indirect effect = 2.64 (95% confidence interval [CI] [1.2, 4.1]) and 2.19 (95% CI [1.3, 3.3]), respectively. Even after PTSS and depressive symptoms were taken into account, the LADS remained significantly associated with somatic symptoms (b = 2.13, p < .05), suggesting partial mediation. CONCLUSION: Exposure to traumatic and adverse events (the LADS) was associated with somatic symptom severity. Furthermore, although PTSS and depressive symptoms partially accounted for the association between the LADS and somatic symptoms, the LADS remained significant, suggesting that both exposure to trauma and adversity and the resultant development of PTSS and depressive symptoms influence the development of somatic symptoms. (PsycINFO Database Record (c) 2018 APA, all rights reserved).
Authors: Ronald C Kessler; Katie A McLaughlin; Jennifer Greif Green; Michael J Gruber; Nancy A Sampson; Alan M Zaslavsky; Sergio Aguilar-Gaxiola; Ali Obaid Alhamzawi; Jordi Alonso; Matthias Angermeyer; Corina Benjet; Evelyn Bromet; Somnath Chatterji; Giovanni de Girolamo; Koen Demyttenaere; John Fayyad; Silvia Florescu; Gilad Gal; Oye Gureje; Josep Maria Haro; Chi-Yi Hu; Elie G Karam; Norito Kawakami; Sing Lee; Jean-Pierre Lépine; Johan Ormel; José Posada-Villa; Rajesh Sagar; Adley Tsang; T Bedirhan Ustün; Svetlozar Vassilev; Maria Carmen Viana; David R Williams Journal: Br J Psychiatry Date: 2010-11 Impact factor: 9.319
Authors: Emma K Adam; Jennifer A Heissel; Katharine H Zeiders; Jennifer A Richeson; Emily C Ross; Katherine B Ehrlich; Dorainne J Levy; Margaret Kemeny; Amanda B Brodish; Oksana Malanchuk; Stephen C Peck; Thomas E Fuller-Rowell; Jacquelynne S Eccles Journal: Psychoneuroendocrinology Date: 2015-08-28 Impact factor: 4.905
Authors: Heidi M Zinzow; Ananda B Amstadter; Jenna L McCauley; Kenneth J Ruggiero; Heidi S Resnick; Dean G Kilpatrick Journal: J Am Coll Health Date: 2011
Authors: Michael P Jones; Lukas Van Oudenhove; Natasha Koloski; Jan Tack; Nicholas J Talley Journal: United European Gastroenterol J Date: 2013-10 Impact factor: 4.623
Authors: Tamra Burns Loeb; Megan T Ebor; Amber M Smith-Clapham; Dorothy Chin; Derek M Novacek; Joya N Hampton-Anderson; Enricka Norwood-Scott; Alison B Hamilton; Arleen F Brown; Gail E Wyatt Journal: Traumatology (Tallahass Fla) Date: 2020-12-10
Authors: Kathleen E Bickel; Richard Kennedy; Cari Levy; Kathryn L Burgio; F Amos Bailey Journal: J Gen Intern Med Date: 2019-12-02 Impact factor: 5.128